ArticleDiabetes, obesity & metabolism2025
Persisting plasma proinsulin levels in a cohort of 482 individuals with long-standing type 1 diabetes mellitus.
Article in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Autologous fecal microbiota capsules are safe and potentially preserve beta-cell function in individuals with type 1 diabetes.Gut microbes · 2025Trial
- Article
- Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion.Diabetic medicine : a journal of the British Diabetic Association · 2026Article
- Stress-driven remodeling of antigen presentation and chemokine signaling in pancreatic β-cells: implications for type 1 diabetes.Frontiers in immunology · 2026Review
- Persisting plasma proinsulin levels in a cohort of 482 individuals with long-standing type 1 diabetes mellitus.Diabetes, obesity & metabolism · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
aimsAs compared with C-peptide, plasma proinsulin levels in individuals with long-standing type 1 diabetes mellitus are relatively understudied, but may serve as a marker of stressed, yet alive β-cells. MATERIALS AND
methodsWe measured proinsulin and C-peptide levels (detection limit <0.15 pmol/L and <0.05 nmol/L, respectively) in a cross-sectional cohort of 482 individuals with type 1 diabetes mellitus and measured associations with diabetes duration, HLA haplotype and autoantibodies.
resultsProinsulin showed a biphasic decline with an initial decrease over 15 years followed by a stabilisation period, whereas C-peptide showed a similar pattern but with an inflection point at ~8 years. Proinsulin and the proinsulin-to-C-peptide ratio did not associate with variables associated with insulin resistance (BMI, triglyceride levels, insulin/day/kg). Higher proinsulin- and C-peptide levels correlated with higher levels of anti-GAD antibodies (Spearman ρ = 0.18 and 0.23 respectively, p < 0.05), but not with anti-IA2. A high-risk DR3/3 HLA genotype associated with complete loss of C-peptide (OR 0.34, 95% CI 0.14-0.79) and proinsulin(OR 0.44, 95% CI 0.20-0.92). CONCLUSIONS/
interpretationIn type 1 diabetes mellitus, proinsulin levels remain detectable long after diagnosis, also in the absence of C-peptide, implying the presence of stressed, yet alive β-cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.